Lifebit

Executive Summary

Lifebit is a UK-based biotechnology company offering a cloud-based Trusted Research Environment (TRE) for secure, federated analysis of sensitive genomic data. Its platform enables researchers to collaborate across institutions without moving data, accelerating precision medicine while maintaining privacy. Serving government health agencies, pharmaceutical companies, and research consortia, Lifebit addresses the growing need for scalable, compliant data infrastructure in genomics. While the company is privately held and lacks public funding or valuation details, its technology positions it well in the expanding precision medicine market, driven by increasing adoption of federated analytics and data privacy regulations.

Upcoming Catalysts (preview)

• Q3 2026Major Contract with UK National Health Service (NHS)50% success
• Q4 2026Partnership with a Top-5 Pharmaceutical Company for Drug Discovery40% success
• Q2 2027Series B Funding Round Announcement70% success